Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.48-0.02 (-0.16%)
At close: 1:00PM EST
12.59 +0.11 (+0.88%)
After hours: 04:48PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
114,028
17,812
48,835
20,653
25,186
Cost of revenue
6,926
1,676
4,101
471
1,702
Gross profit
107,102
16,136
44,734
20,182
23,484
Operating expenses
Research development
180,633
122,964
107,068
84,888
66,962
Selling general and administrative
104,417
67,929
37,121
29,514
13,933
Total operating expenses
285,050
190,893
144,189
114,402
80,895
Operating income or loss
-177,948
-174,757
-99,455
-94,220
-57,411
Interest expense
46,123
14,501
11,892
9,176
8,565
Total other income/expenses net
-3,281
-2,976
517
-108
-821
Income before tax
-226,776
-182,814
-108,897
-101,252
-65,782
Income from continuing operations
-226,776
-182,814
-108,897
-101,252
-65,782
Net income
-226,776
-182,814
-108,897
-101,252
-65,782
Net income available to common shareholders
-226,776
-182,814
-108,897
-101,252
-65,782
Basic EPS
-
-1.09
-0.94
-0.98
-0.78
Diluted EPS
-
-1.09
-0.94
-0.98
-0.78
Basic average shares
-
167,267
115,600
103,185
84,451
Diluted average shares
-
167,267
115,600
103,185
84,451
EBITDA
-
-167,565
-96,281
-91,306
-56,513